Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05578092
Title A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mirati Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Local Institution - 001-113 NOT_YET_RECRUITING Washington District of Columbia 20016-2633 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists RECRUITING Orlando Florida 32827-7400 United States Details
Johns Hopkins University RECRUITING Baltimore Maryland 21287 United States Details
Local Institution - 001-110 NOT_YET_RECRUITING Rochester Minnesota 55905-0001 United States Details
University of Cincinnati Cancer Institute RECRUITING Cincinnati Ohio 45219-2364 United States Details
Local Institution - 001-109 ACTIVE_NOT_RECRUITING Portland Oregon 97239-3011 United States Details
Local Institution - 001-102 COMPLETED Nashville Tennessee 37203 United States Details
Sarah Cannon Research Institute Central Office RECRUITING Nashville Tennessee 37203 United States Details
Local Institution - 001-112 NOT_YET_RECRUITING Dallas Texas 75246-2003 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Virginia - NEXT Oncology - PPDS RECRUITING Fairfax Virginia 22031 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
Pan American Center for Oncology Trials, LLC RECRUITING Rio Piedras 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field